Instil Bio Files Q1 2025 10-Q

Ticker: TIL · Form: 10-Q · Filed: May 13, 2025 · CIK: 1789769

Instil Bio, INC. 10-Q Filing Summary
FieldDetail
CompanyInstil Bio, INC. (TIL)
Form Type10-Q
Filed DateMay 13, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, biotechnology, financials

TL;DR

Instil Bio's Q1 2025 10-Q is in. Check financials.

AI Summary

Instil Bio, Inc. filed its Q1 2025 10-Q report on May 13, 2025, detailing its financial position as of March 31, 2025. The company, operating in the biological products sector, is based in Dallas, TX, and its fiscal year ends on December 31st. The filing covers the period from January 1, 2025, to March 31, 2025.

Why It Matters

This filing provides investors with a quarterly update on Instil Bio's financial health and operational status, crucial for understanding its performance in the biotechnology sector.

Risk Assessment

Risk Level: medium — Biotechnology companies often face high development costs and regulatory hurdles, making their financial performance inherently volatile.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Instil Bio, Inc.?

Instil Bio, Inc. is in the business of Biological Products (No Diagnostic Substances), as indicated by its SIC code [2836].

When was this 10-Q report filed with the SEC?

This 10-Q report was filed on May 13, 2025.

What period does this 10-Q filing cover?

This filing covers the period from January 1, 2025, to March 31, 2025.

Where is Instil Bio, Inc. located?

Instil Bio, Inc.'s business address is located at 3963 Maple Avenue, Suite 350, Dallas, TX 75219.

What is Instil Bio's fiscal year end?

Instil Bio's fiscal year ends on December 31st.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Instil Bio, Inc. (TIL).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing